We are working with a protein that modulates the genetic information to generate different proteins from the same gene. These proteins might even have opposite functions. This process is called alternative splicing.

We hypothesize that alternative splicing could be a novel mechanism of regulation of the resistance to targeted therapy in lung cancer. This project will allow the identification of key elements of this resistance.